Inimmune

Inimmune (Missoula, MT) is a clinical stage biotechnology company located in Missoula, MT (USA) focused on developing the next generation of vaccines and immunotherapeutics. The group has extensive expertise in synthetic and process chemistry, drug formulation, and immunology. Our pipeline includes innovative new treatments to harness the innate immune system in areas of critical patient need such as oncology, allergic rhinitis, food allergy and infectious disease vaccines. Inimmune and ImmunAdd in Taipei, Taiwan have partnered to co-develop an improved synthetic “AS01 like” adjuvant. This Synthetic Adjuvant System (SAS) overcomes the challenges associated with resource limited and costly natural product production and isolation. SAS combines innovative and patented adjuvant technologies from Inimmune and ImmunAdd in a liposome based delivery system as a synthetic alternative to AS01.